Revium Rx (RVRC) Retained Earnings (2024 - 2025)
Revium Rx's (RVRC) quarterly Retained Earnings came in at -$25.0 million in Q4 2025, down 116.82% year-on-year from $148.4 million in Q4 2024, and down 116.82% quarter-over-quarter from -$11.5 million in Q4 2024.
Revium Rx (RVRC) Retained Earnings (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Retained Earnings across 2 years of filings, most recently posting -$25.0 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$25.0 million, down 116.82% year-over-year; the trailing twelve-month figure through Dec 2025 was -$25.0 million (down 116.82% YoY), and the FY2025 annual result was -$25.0 million, down 116.82% from the prior year.
- Retained Earnings came in at -$25.0 million for Q4 2025 at Revium Rx, down from -$11.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$11.5 million in Q4 2024 to a low of -$25.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 4.62 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 14.14 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 177.20 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -348,000.00 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -1.52 Bn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 28,000.00 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 846,000.00 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -153.25 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -10.64 Mn |
| 10 | Revium Rx | - | - | - | -24.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.96 Mn |
| Dec 31, 2024 | -11.51 Mn |